DRD4 (Dopamine D4 Receptor) Mitigate Abdominal Aortic Aneurysm via Decreasing P38 MAPK (mitogen-activated protein kinase)/NOX4 (NADPH Oxidase 4) Axis–Associated Oxidative Stress

Author:

Liu Xuesong1,Guo Yansong2,Yang Yuxue3,Qi Chunlei1,Xiong Ting1,Chen Yue4,Wu Gengze4,Zeng Chunyu4ORCID,Wang Daxin3ORCID

Affiliation:

1. Department of Cardiology, The Second Xiangya Hospital, Central South University, Changsha, China (X.L., C.Q., T.X.).

2. Department of Cardiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fujian Provincial Key Laboratory of Cardiovascular Disease, Fujian Cardiovascular Institute, Fuzhou, China (Y.G.).

3. The Hospital Affiliated to Medical School of Yangzhou University (Taizhou People’s Hospital), China (Y.Y., D.W.).

4. Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, China (Y.C., G.W., C.Z.).

Abstract

Oxidative stress plays a vital role in the development of abdominal aortic aneurysm (AAA). DRD4 (dopamine D4 receptor) is involved in oxidative stress. Here, we reasoned that DRD4 may mitigate AAA by its antioxidative effect. Currently, in vivo, DRD4 expression was reduced in AAA patients and experimental models determined by quantitative polymerase chain reaction and Western blot. Reactive oxygen species (ROS) was increased in elastase perfused aorta from Drd4 −/− mice compared with elastase perfused wild-type ( WT ) aorta determined by dihydroethidium staining and malondialdehyde, accompanying with more apoptotic vascular smooth muscle cells, inflammatory infiltration, and ECM (extracellular matrix) degradation determined by terminal deoxynucleotidyl transferase-mediated nick end labeling assay, immunohistochemistry, Van Gieson staining, and zymography, respectively. However, pharmacological activation of DRD4 reduced the ROS production and mitigated pathological characteristics of AAA. In vitro, activated DRD4 alleviated ROS production and apoptosis determined by 2,7-dichlorodihydrofluorescein diacetate, dihydroethidium, malondialdehyde, and flow cytometry, whereas DRD4 deficiency or inhibited DRD4 exerted the opposite effect in vascular smooth muscle cells. In terms of mechanism, in vivo, DRD4 deficiency upregulated NOX4 (NADPH oxidase 4) expression instead of other subunits, meanwhile, phosphorylated P38 mitogen-activated protein kinase was also augmented instead of other mitogen-activated protein kinase pathways. In vitro, pharmacological activation of DRD4 downregulated phosphorylated P38 and NOX4 in vascular smooth muscle cells, vice versa. Interestingly, DRD4 mediated the expression of NOX4 through a P38 mitogen-activated protein kinase pathway–dependent manner, which regulated ROS production. DRD4 mitigated AAA progression by downregulating P38 mitogen-activated protein kinase/NOX4 axis mediated ROS production in vascular smooth muscle cells. Therefore, DRD4 may serve as a novel therapeutic target for AAA treatment.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3